SystImmune
WA - RedmondBiotechnology
Focus: SystImmune is a Redmond-based biotech specializing in bi-specific and multi-specific antibodies plus antibody-drug conjugates for oncology and neurology. The company operates a large, early-stage pipeline focused on solid tumors and hematologic malignancies.
Profile data last refreshed 4h ago · AI intelligence enriched 1w ago
Open Jobs
46+57 this month
Hot — 68 jobs added in 30d
Net +57 (68 new, 11 removed). Aggressive expansion phase.
Should You Work at SystImmune?
AI assessmentBest suited for scientists and operators who thrive in discovery-stage biotech and tolerate pre-revenue risk in exchange for platform influence and early equity upside.
Why Work Here
- Heavy R&D hiring (10 open roles) signals active drug discovery and platform expansion in high-value oncology/neurology modalities.
- Diverse pipeline across 12+ distinct programs provides exposure to multiple therapeutic mechanisms and indication areas within a small-team environment.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
26 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
GNC-039
Recurrent GliomaClinical Trials (1)
NCT04794972A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors
Phase 1Help build intelligence for SystImmune
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.